MacuMira is a noninvasive treatment that does not involve injections or medications. Instead, it uses microcurrent stimulation to enhance blood flow, nourishing the macula while stimulating cellular regeneration to improve retinal health.
Treatments are tailored specifically to each patient and generally consist of a series of 4 sessions over 10 days, with each session lasting approximately 30 minutes. During treatment, patients are seated comfortably while a specialized headset gently delivers microcurrent stimulation to closed eyes.
Most patients start to experience results within the first 10 days of treatment. To maintain results, follow-up sessions are scheduled approximately every 2.5 to 3 months.
Dry AMD is a progressive condition that impacts the macula, the central portion of the retina responsible for sharp, detailed vision. It affects millions of Canadians over the age of 50 and is a leading cause of visual impairment.
If left untreated, dry AMD can severely limit your independence and daily function. MacuMira provides hope through clinically tested, restorative care.
What Causes Dry AMD?
Dry age-related macular degeneration (AMD) is caused by damage to the macula, the part of the retina responsible for sharp central vision. This damage typically results from aging, poor blood flow, and the gradual breakdown of retinal cells.
When retinal tissue becomes weakened or undernourished, it can no longer support the visual detail we rely on in daily life. This leads to central vision loss, making tasks like reading or recognizing faces more difficult.
Over time, the retina loses its ability to regenerate healthy cells. This decline in cellular activity can cause the macula to thin and weaken, leading to vision distortion or central blind spots.
Inadequate circulation means the retina receives less oxygen and fewer nutrients. Without proper nourishment, retinal cells begin to break down, contributing to progressive vision loss.
In one clinical trial, the treatment restored sight for 100% of patients. Many also reported improved contrast sensitivity, making it easier to see in low-light conditions.
Our team of highly qualified professionals is dedicated to providing patient-centred care. Our goal is not only to restore vision but to restore confidence, independence, and quality of life for those living with dry AMD.
MacuMira helps restore clarity in your central vision, making it easier to read, recognize faces, and carry out everyday tasks with more confidence.
Enjoy comfortable treatments with no injections, medications, or downtime. MacuMira uses safe, microcurrent technology for effective results.
Experience better vision in low-light conditions. MacuMira improves your ability to distinguish between light and dark, even in dim environments.
MacuMira promotes blood flow and stimulates retinal cells, supporting long-term macular health and helping slow the progression of dry AMD.
In clinical trials, 100% of patients experienced visual improvement. Most noticed results within 10 days of starting the treatment protocol.
You don’t need to be a Family Eye Care patient to receive MacuMira. Book directly with us, your optometrist can continue providing your routine care.
At Family Eye Care, our knowledgeable doctors and staff are here to meet all of your visual needs and provide you with excellent quality eye care. We strive to always provide you with the best service, most current information and education, and the best products on the market.